Concomitant Anticonvulsants With Bitemporal Electroconvulsive Therapy
- 1 March 2017
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Journal of ECT
- Vol. 33 (1), 16-21
- https://doi.org/10.1097/yct.0000000000000357
Abstract
Electroconvulsive therapy (ECT) is an effective treatment for major affective disorders. The combined use of ECT and anticonvulsant mood stabilizers is a common clinical scenario. There is dearth of systematic studies on the use of this combination with regard to clinical or cognitive outcomes. We aimed to compare clinical improvement and cognitive adverse effects between patients who received only ECT versus those who received ECT and anticonvulsants. We hypothesized that improvement would be fastest in patients who received only ECT. We conducted a randomized controlled trial in which patients prescribed ECT while being treated with anticonvulsants were randomized into 3 groups: full-dose (FD), half-dose (HD), and stop anticonvulsant. A blind rater assessed clinical improvement in patients using rating scales [Young’s Mania Rating Scale (YMRS) and Clinical Global Impression] for clinical improvement and cognitive adverse effects (Postgraduate Institute memory scale). Analysis was done using mixed-effects modeling to delineate differences in clinical and cognitive outcomes across the 3 arms of the study over the course of ECT. Of the 54 patients recruited, 36 patients went into treatment allocation arms per the initial randomization plan. The main anticonvulsants prescribed were sodium valproate and carbamazepine. Patients in the 3 groups were comparable on clinical features. The most common diagnosis was bipolar affective disorder—with current episode of mania. Overall, there was no difference across the 3 groups in final clinical outcome scores (YMRS and Clinical Global Impression) when analyzed as intention to treat (ITT) or “as treated.” In both analyses, group × time interaction was significant when comparing trend of YMRS scores between the FD anticonvulsant group and the HD group from baseline to last ECT (P = 0.0435 in ITT and P = 0.0055 in as treated). Patients in the FD group improved faster than those in the HD group. There were no differences across the 3 groups with regard to their cognitive adverse effects in the ITT analysis; “as-treated analysis” showed the HD patients to have performed poorly on some domains. Seizure parameters showed no significant difference across the 3 groups. This is a preliminary prospective study examining whether coprescription of anticonvulsants with ECT affected clinical or cognitive outcomes. The most important takeaway point from this study is the significant reduction in YMRS scores when ECT was given with FD anticonvulsant compared with halving the dose (HD) of anticonvulsant. This difference was shown in both ITT and as-treated analysis. There is a need for more prospective studies to examine this clinical question.This publication has 10 references indexed in Scilit:
- Assessment of Cognitive Impairments and Seizure Characteristics in Electroconvulsive Therapy with and without Sodium Valproate in Manic PatientsNeuropsychobiology, 2012
- Comparing Efficacy of ECT With and Without Concurrent Sodium Valproate Therapy in Manic PatientsThe Journal of ECT, 2012
- Comparison of electroconvulsive therapy (ECT) with or without anti-epileptic drugs in bipolar disorderJournal of Affective Disorders, 2010
- Antiepileptic drugs–ECT combination: Need for systematic studiesThe World Journal of Biological Psychiatry, 2010
- Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literatureThe World Journal of Biological Psychiatry, 2009
- Anticonvulsants During Electroconvulsive TherapyThe Journal of ECT, 2007
- The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (Second Edition).The Journal of ECT, 2002
- The Declaration of Helsinki: revising ethical research guidelines for the 21st centuryThe Medical Journal of Australia, 2000
- The Helsinki Declaration, research guidelines and regulations: present and future editorial aspectsActa Anaesthesiologica Scandinavica, 1996
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978